Neuroscience
Placebo
69%
In Vivo
57%
Oxytocin
50%
Methylene Blue
50%
Ketamine
50%
Parkinson's Disease
50%
Cerebrovascular Disease
50%
Translocator Protein
50%
Mismatch Negativity
50%
positron emission tomographic scan
50%
Metabolic Pathway
50%
Mifepristone
50%
Protein Binding
50%
Functional Magnetic Resonance Imaging
36%
Magnetic Resonance Imaging
33%
Antipsychotic
33%
Visual Hallucination
22%
Brain Metabolism
21%
Brain Activation
18%
Staining Technique
16%
Olanzapine
16%
Risperidone
16%
Quantitative Imaging
16%
Crossover Study
16%
Blood Plasma
16%
Haloperidol
16%
Microglia
16%
Antidepressant
16%
Hallucination
16%
Nose
14%
Glucocorticoid Receptor
13%
Amygdala
12%
Ventral Tegmental Area
11%
Brain Areas
11%
Serotonergic
11%
Psychotomimetic
11%
Immunohistochemistry
11%
Cognitive Disorders
10%
Working Memory
9%
Electroencephalogram
9%
Neuroprotective Agent
7%
Antioxidant
7%
Nasal Spray
7%
In Vitro
7%
Ventral Striatum
5%
Receptor Trafficking
5%
Treatment Development
5%
Putamen
5%
Dorsal Striatum
5%
Nucleus Accumbens
5%
Immunology and Microbiology
Brain Blood Flow
100%
Oxytocin
50%
White Matter
50%
positron emission tomographic scan
50%
Protein Binding
50%
Brain Metabolism
37%
Metabolic Rate
25%
Microglia
21%
Nose
14%
Normal Human
12%
Protein Expression
7%
Capillary
7%
Peptides
7%
Brain Region
7%
Macrophage
7%
Systemic Circulation
7%
Amygdala
7%
Perfusion
7%
Medicine and Dentistry
Mitochondrial Membrane Transport Protein
50%
Positron Emission Tomography
50%
Cerebrovascular Disease
50%
Protein Binding
50%
Small Vessel Disease
44%
Microglia
16%
Carbon 11
11%
Immunohistochemistry
11%
Protein Ligand
5%
Cognitive Defect
5%
Ischemia
5%
Radioactive Tracer
5%
Vascular Dementia
5%
Biological Marker
5%
Protein Expression
5%
Macrophage
5%
Capillary
5%
